title: [Development of NSAID-induced small intestinal lesions - pathogenic role of COX inhibition].
authors.affiliation: takeuchi@mb.kyoto-phu.ac.jp
authors.forename: Koji
authors.initials: K
authors.lastname: Takeuchi
authors.forename: Akiko
authors.initials: A
authors.lastname: Tanaka
authors.forename: Shinichi
authors.initials: S
authors.lastname: Kato
authors.forename: Kikuko
authors.initials: K
authors.lastname: Amagase
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000494:pharmacology; D001241:Aspirin / Q000009:adverse effects / Q000494:pharmacology; D051545:Cyclooxygenase 1 / Q000502:physiology; D051546:Cyclooxygenase 2 / Q000502:physiology; D016861:Cyclooxygenase Inhibitors; D015232:Dinoprostone / Q000096:biosynthesis; D006801:Humans; D007410:Intestinal Diseases / Q000139:chemically induced*; D007421:Intestine, Small / Q000378:metabolism; D009569:Nitric Oxide / Q000502:physiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D009569:Nitric Oxide; D051545:Cyclooxygenase 1; D051546:Cyclooxygenase 2; C496511:PTGS1 protein, human; C496540:PTGS2 protein, human; D015232:Dinoprostone; D001241:Aspirin